Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory ILC2-Role of IL-10 Producing ILC2 in Asthma. | Cells | 2023 | 37947634 | PubTator, text mining | PubMed |
| NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics? | Front Immunol | 2023 | 37928543 | PubTator, text mining | PubMed |
| Impact of a new liver immune status index among patients with hepatocellular carcinoma after initial hepatectomy. | Ann Gastroenterol Surg | 2023 | 37927921 | PubTator, text mining | PubMed |
| ILC3: a case of conflicted identity. | Front Immunol | 2023 | 37915588 | PubTator, text mining | PubMed |
| Group 3 Innate Lymphoid Cells Exacerbate Lupus Nephritis by Promoting B Cell Activation in Kidney Ectopic Lymphoid Structures. | Adv Sci (Weinh) | 2023 | 37915129 | PubTator, text mining | PubMed |
| Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations. | Neoplasia | 2023 | 37913654 | PubTator, text mining | PubMed |
| Protein Tyrosine Phosphatase CD45 As an Immunity Regulator and a Potential Effector of CAR-T therapy. | Acta Naturae | 2023 | 37908772 | PubTator, text mining | PubMed |
| Innate lymphoid cells: a new key player in atopic dermatitis. | Front Immunol | 2023 | 37908364 | PubTator, text mining | PubMed |
| Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function. | Front Immunol | 2023 | 37908353 | PubTator, text mining | PubMed |
| Intervention Effects of Physical Activity on Type 2 Diabetic Patients Potentially Infected with COVID-19. | Medicina (Kaunas) | 2023 | 37893490 | PubTator, text mining | PubMed |
| Natural Killer Repertoire Restoration in TB/HIV Co-Infected Individuals Experienced an Immune Reconstitution Syndrome (CAMELIA Trial, ANRS 12153). | Pathogens | 2023 | 37887757 | PubTator, text mining | PubMed |
| Exploring pathway interactions to detect molecular mechanisms of disease: 22q11.2 deletion syndrome. | Orphanet J Rare Dis | 2023 | 37872602 | PubTator, text mining | PubMed |
| Single-cell characterization of self-renewing primary trophoblast organoids as modeling of EVT differentiation and interactions with decidual natural killer cells. | BMC Genomics | 2023 | 37853336 | PubTator, text mining | PubMed |
| A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma. | Cancers (Basel) | 2023 | 37835538 | PubTator, text mining | PubMed |
| Functional TRPA1 Channels Regulate CD56dimCD16+ NK Cell Cytotoxicity against Tumor Cells. | Int J Mol Sci | 2023 | 37834182 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma. | Front Immunol | 2023 | 37818374 | PubTator, text mining | PubMed |
| In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy. | Front Immunol | 2023 | 37818372 | PubTator, text mining | PubMed |
| Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity. | Cancer Biol Med | 2023 | 37817484 | PubTator, text mining | PubMed |
| The role of angiogenic growth factors in the immune microenvironment of glioma. | Front Oncol | 2023 | 37790751 | PubTator, text mining | PubMed |
| Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway. | Biomark Res | 2023 | 37784183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=10